Research · Sep 3, 2026
[NEM] Newmont Thesis 2026: Newcrest Synergies + Divestiture Program Completion + Gold Price Strength Anchor Capital Return Normalization
Newmont FY2025 revenue ~$19-21B (+5-8%) with adj. EPS ~$3.30-3.70 reflecting continued gold price strength ($2,400-2,600/oz average vs $2,275 FY2024 + $1,954 FY2023 — record highs) on central bank gold purchases (record 1,000+ tonnes/yr official sector buying FY2022-2024) + geopolitical safe haven demand + dollar weakness expectations + ETF inflows. Largest gold producer globally after Newcrest Mining $16.8B all-stock acquisition closed November 2023 (added Lihir PNG ~700K oz + Cadia NSW ~600K oz copper-gold porphyry + Brucejack BC ~300K oz high-grade underground + Telfer WA + Havieron + Wafi-Golpu development projects). 5 geographic regions: North America 25% + South America 15% + Australia 25% + Africa 13% + Asia Pacific 17%. CEO Tom Palmer since Oct 2019 (recovered from cancer 2023; selected interim leadership). Newcrest synergy realization: $205M FY2024 actual; FY2025 expected $350-400M cumulative; FY2026 target $500M run-rate. Divestiture program $2-3B selected non-core asset sales (Telfer + Akyem + selected) underway. Capital return framework constrained by deleveraging: base dividend $1.00/share (re-baseline from $1.60 FY2023 + $2.20 FY2022); variable dividend suspended; buybacks $0.5-1.0B; total $1.6-2.1B vs target $4-5B post-deleveraging. FY2026 thesis: Newcrest synergies year-2 + divestiture completion + capital return normalization with variable dividend reinstatement + gold price strength durability. Risks: gold price weakness, Newcrest synergies disappoint, operational disruptions.